Reminder: canSERV Call for Service Provision "Training the Next Generation of Cancer Researchers"
One document
more
4.5.5
Stories about Krebs
- Language:
- Media:
- Period:
- Period:Total
Last Call for canSERV Third Open Call Funding
One documentmoreLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
One documentmoreLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
One documentmore- 2
Record financing rounds at the Munich biotech hub
One documentmore canSERV relaunches Open Call for Service Provision
One documentmore
canSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 DocumentsmorecanSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmore- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
One documentmore Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
One documentmore
Strengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmore- 2
OPTIMA cancer project announces the Region Uppsala as new partner
more - 2
PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHub
more - 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
One documentmore canSERV Releases Open Call for Transnational Service Provision
One documentmore- 4
PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets
more
WildDISCO: Visualizing Whole Bodies in Unprecedented Detail
morePotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
more- 3
Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca Biotech
more
The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
moreCHRISTMAS COMES EARLY FOR CHILDREN WITH CANCER COURTESY OF PM-INTERNATIONAL MALAYSIA
moreNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
more- 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore - 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore
12Next